intraocular pressure

Deciding between glaucoma or physiologic cuppingBig optic nerves make me feel good. I find them easier to evaluate, and I don’t get as worked up about their respective big optic cups.
Decade ahead to bring momentous advances in glaucoma careThe next decade will be a period of remarkable research discoveries for glaucoma and their translation into enhanced patient care, according to Robert N. Weinreb, MD.
Micro-stent may be stand-alone option when topical glaucoma therapy failsSupraciliary micro-stent implantation can serve as a safe and effective stand-alone treatment in patients refractory to topical glaucoma therapy.
Fixed dose of ROCK/NET inhibitor, latanoprost meets endpointA fixed-dose combination containing an investigational rho kinase/norepinephrine transporter inhibitor and latanoprost 0.005% achieved its primary endpoint, showing potential as a high-efficacy, IOP-lowering therapy in a phase IIb trial.
Novel use of endoscope helps to visualize hyphemaA glaucoma specialist explores endoscopic visualization for the diagnosis and treatment of uveitic-glaucoma-hyphema syndrome.
Nanophotonics-based implant may enable at-home IOP monitoringA nanophotonics-based device implanted in the eye may one day enable patients with glaucoma to monitor their IOP from home.
AAOphth says marijuana is not proven treatment for glaucomaThe American Academy of Ophthalmology (AAOphth) has reiterated its stance on medical marijuana for the treatment of glaucoma, stating that it finds no scientific evidence that marijuana is an effective long-term treatment for the disease, particularly when compared to the current prescription medication and surgical treatment available.
Understanding circadian patterns, drug efficacy could improve careKnowledge about the circadian pattern of IOP and the 24-hour efficacy of glaucoma medications is increasing, which is expected to improve medical management of glaucoma in the future.
Beyond IOP in glaucoma treatmentIntraocular pressure (IOP) is only the starting point for glaucoma treatment. Successful treatment begins with establishing an IOP goal, but there are multiple considerations that affect treatment choices. Robert Stamper, MD, explored the considerations that go into drug selection. None of the factors that should influence drug selection are new, he said, but it is easy to forget that the patient with glaucoma likely has other medical problems and is taking other medications.
CO2 laser surgery a new option for glaucomaCO2 laser-assisted sclerectomy surgery reduces elevated IOP by thinning the sclera of the eye while leaving an intact membrane.